CLINICAL_TRIALS
trial_result
· 2022-09-21
Clinical Trial Update: DIalysis Symptom COntrol-Restless Legs Syndrome Trial [Phase 3]
Summary
Phase 3 trial update for a dialysis-related symptom control program targeting Restless Legs Syndrome in patients with End Stage Renal Disease; the study status …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Population Health Research Institute | Conditions: End Stage Renal Disease, Restless Legs Syndrome | Phase 3 | Status: COMPLETED